Company / Cash per Share
ENANTA PHARMACEUTICALS INC Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.52
FY2025
5-year range
$1.52 / $4.11
FY2021-FY2025
Trend
-13.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share has fluctuated over the past 10 years, ranging from $1.14 in FY2017 to $4.42 in FY2020.
Based on SEC 10-K filings.
1.52 in FY2025 with a 5-year CAGR of -19.2%.
Declined from $4.11 to $1.52 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -11.2%
- 5-Year CAGR
- -19.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, cash per share decreased 13.8% year-over-year.
- Peak cash per share was recorded in FY2020.
- Lowest cash per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.52 | -13.8% |
| FY2024 | $1.77 | -57.0% |
| FY2023 | $4.11 | +88.9% |
| FY2022 | $2.17 | -23.7% |
| FY2021 | $2.85 | -35.6% |
| FY2020 | $4.42 | +67.4% |
| FY2019 | $2.64 | -21.0% |
| FY2018 | $3.34 | +192.8% |
| FY2017 | $1.14 | -30.4% |
| FY2016 | $1.64 | +244.3% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026